# Bioequivalence Study: 3 mg Estradiol Valerate (EV) With and Without Levomefolate Calcium

> **NCT01031355** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 42 (actual)

## Conditions studied

- Contraception
- Ovulation Inhibition

## Interventions

- **DRUG:** Estradiol Valerate (EV) / Levomefolate Calcium (BAY98-7078)
- **DRUG:** Estradiol Valerate (EV) (BAY86-4980)
- **DRUG:** Levomefolate Calcium (BAY86-7660)

## Key facts

- **NCT ID:** NCT01031355
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-02
- **Final completion:** 2010-03
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2014-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01031355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01031355, "Bioequivalence Study: 3 mg Estradiol Valerate (EV) With and Without Levomefolate Calcium". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT01031355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*